MIMS® Retrospective Chart Review
Not yet recruiting
- Conditions
- Open Angle Glaucoma
- Interventions
- Device: Minimally Invasive Micro Sclerostomy
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT06614218
- Locations
- 🇦🇲
S. Malayan Eye Center, Yerevan, Armenia
Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study
Completed
- Conditions
- Open Angle Glaucoma
- Interventions
- Device: Minimally Invasive Micro Trabeculostomy
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT06612346
- Locations
- 🇦🇲
S. Malayan Eye Center, Yerevan, Armenia
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Recruiting
- Conditions
- Open Angle Glaucoma
- Interventions
- Device: Inferonasal Minimally Invasive Micro Sclerostomy
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT06577857
- Locations
- 🇦🇲
S. Malayan Eye Center, Yerevan, Armenia
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Not Applicable
Recruiting
- Conditions
- Primary Open Angle GlaucomaOpen Angle Glaucoma
- Interventions
- Device: Minimally Invasive Micro Sclerostomy Device
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 129
- Registration Number
- NCT06313749
- Locations
- 🇺🇸
Glaucoma Associates of Texas, Dallas, Texas, United States
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study
Not Applicable
Completed
- Conditions
- This Study is Conducted Under Inclusion/ Exclusion Criteria
- Interventions
- Device: MIMS
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 83
- Registration Number
- NCT05638321
- Locations
- 🇦🇲
S.V.Malayan'S Eye Center, Yerevan, Armenia
Minimally Invasive Nasal Trabeculostomy - Performance and Safety Evaluation Study
Not Applicable
Completed
- Conditions
- This Study is Obtained Under Inclusion/ Exclusion Criteria
- Interventions
- Device: MINT
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 71
- Registration Number
- NCT05638906
- Locations
- 🇦🇲
S.V.Malayan'S Eye Center, Yerevan, Armenia
Minimally Invasive Micro Sclerostomy: Performance and Safety Evaluation Study
Not Applicable
Completed
- Conditions
- Glaucoma
- Interventions
- Device: Minimally Invasive Micro Sclerostomy (MIMS)
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT04503590
- Locations
- 🇦🇲
S.V.Malayan'S Eye Center, Yerevan, Armenia
Minimally Invasive Micro Sclerostomy: Safety and Preliminary Performance Study
Not Applicable
Completed
- Conditions
- Glaucoma
- Interventions
- Device: Minimally Invasive Micro Sclerostomy (MIMS)
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT04484155
- Locations
- 🇮🇳
Dr. Agarwal Eye Hospital Ltd., Chennai, India
Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study
Not Applicable
Completed
- Conditions
- Pigmentary GlaucomaPseudoexfoliative GlaucomaPrimary Open Angle Glaucoma
- Interventions
- Procedure: Minimally Invasive Micro Sclerostomy
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Sanoculis Ltd
- Target Recruit Count
- 96
- Registration Number
- NCT02355990
- Locations
- 🇮🇱
Goldschleger Eye Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel
© Copyright 2025. All Rights Reserved by MedPath